<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Prime Drink Group Corp. (formerly Was Dwr/dominion Water Reserves Corp. Until 2022-11-22) — News on 6ix</title>
<link>https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22</link>
<description>Latest news and press releases for Prime Drink Group Corp. (formerly Was Dwr/dominion Water Reserves Corp. Until 2022-11-22) on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 16 Apr 2026 12:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22" rel="self" type="application/rss+xml" />
<item>
<title>Prime Medicine Appoints Svetlana Makhni as Chief Financial Officer</title>
<link>https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-medicine-appoints-svetlana-makhni-as-chief-financial-officer</link>
<guid isPermaLink="true">https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-medicine-appoints-svetlana-makhni-as-chief-financial-officer</guid>
<pubDate>Thu, 16 Apr 2026 12:00:00 GMT</pubDate>
<description>CAMBRIDGE, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biote...</description>
</item>
<item>
<title>The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step</title>
<link>https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/the-dollar578-billion-regenerative-medicine-market-has-a-manufacturing-problem-one-company-just-solved-the-first-step</link>
<guid isPermaLink="true">https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/the-dollar578-billion-regenerative-medicine-market-has-a-manufacturing-problem-one-company-just-solved-the-first-step</guid>
<pubDate>Wed, 01 Apr 2026 00:49:00 GMT</pubDate>
<description>The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solve...</description>
</item>
<item>
<title>Advanced Cell-based Therapy Booming the Success for Healthcare Sector</title>
<link>https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/advanced-cell-based-therapy-booming-the-success-for-healthcare-sector</link>
<guid isPermaLink="true">https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/advanced-cell-based-therapy-booming-the-success-for-healthcare-sector</guid>
<pubDate>Tue, 24 Mar 2026 14:00:00 GMT</pubDate>
<description>Advanced Cell-based Therapy Booming the Success for Healthcare Sector Canada NewsWire ...</description>
</item>
<item>
<title>Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates</title>
<link>https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-medicine-reports-full-year-2025-financial-results-and-provides-business-updates</link>
<guid isPermaLink="true">https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-medicine-reports-full-year-2025-financial-results-and-provides-business-updates</guid>
<pubDate>Tue, 03 Mar 2026 13:00:00 GMT</pubDate>
<description>-- On track to file IND and/or CTA for Wilson Disease and AATD programs in 1H 2026 and mid-2026, ...</description>
</item>
<item>
<title>Prime Drink Group Announces Management Change</title>
<link>https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-drink-group-announces-management-change</link>
<guid isPermaLink="true">https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-drink-group-announces-management-change</guid>
<pubDate>Fri, 27 Feb 2026 22:15:00 GMT</pubDate>
<description>MONTRÉAL, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) is pleased to announce the appointment of Germain Turpin as Interim President and Chief Executive Officer of the Company. Mr. Turpin succeeds Alexandre Côté, who will step down from his position on February 28, 2026, while remaining on the Board of Directors and retaining responsibility for special projects. Germain Turpin has over 20 years of experience in the water industry in Québec. For</description>
</item>
<item>
<title>Prime Drink Group Secures Exclusive North American Licenses for Beach Day Every Day</title>
<link>https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-drink-group-secures-exclusive-120000580</link>
<guid isPermaLink="true">https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-drink-group-secures-exclusive-120000580</guid>
<pubDate>Fri, 06 Feb 2026 12:00:00 GMT</pubDate>
<description>MONTREAL, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) is pleased to announce that it has secured exclusive licenses from Prime Capital Investments Inc. for the rights to certain Beach Day Every Day ("BDED") trademarks, in exchange for royalties and marketing and promotion fees. These licenses will allow Prime to use the BDED brand exclusively in connection with the production and commercialization of ready-to-drink beverages and low-calorie co</description>
</item>
<item>
<title>Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference</title>
<link>https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-medicine-to-present-at-44th-annual-jp-morgan-healthcare-conference</link>
<guid isPermaLink="true">https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-medicine-to-present-at-44th-annual-jp-morgan-healthcare-conference</guid>
<pubDate>Wed, 07 Jan 2026 13:00:00 GMT</pubDate>
<description>CAMBRIDGE, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotec...</description>
</item>
<item>
<title>Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize</title>
<link>https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/gene-therapy-5-biotech-stocks-chasing-the-dollar36b-prize</link>
<guid isPermaLink="true">https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/gene-therapy-5-biotech-stocks-chasing-the-dollar36b-prize</guid>
<pubDate>Fri, 02 Jan 2026 18:29:00 GMT</pubDate>
<description>Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize Canada NewsWire Issued on b...</description>
</item>
<item>
<title>Prime Drink Group Announces First Closing of Private Placement and Grant of Stock Options</title>
<link>https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-drink-group-announces-first-000000514</link>
<guid isPermaLink="true">https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-drink-group-announces-first-000000514</guid>
<pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
<description>MONTREAL, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces a first closing of its previously announced non-brokered private placement offering of units of the Company (the “Unit Offering”) for gross proceeds of $450,000. As a result, the Company issued 7,500,015 common shares in the capital of the Company (the “Common Shares”) and 7,500,015 warrants. Each warrant entitles the holder to purchase one Common Share at a price of $0.06 per sha</description>
</item>
<item>
<title>Prime Drink Group Announces Private Placement</title>
<link>https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-drink-group-announces-private-233800156</link>
<guid isPermaLink="true">https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-drink-group-announces-private-233800156</guid>
<pubDate>Wed, 17 Dec 2025 23:38:00 GMT</pubDate>
<description>MONTREAL, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces that it is proceeding with a non-brokered private placement offering of units of the Company (the “Units”) to raise minimum gross proceeds of $300,000 and maximum gross proceeds of $5,000,000 (the “Unit Offering”). Each Unit will be offered at a price of $1,000 per Unit and is comprised of 16,667 common shares in the capital of the Company (the “Common Shares”) and 16,667 transfer</description>
</item>
<item>
<title>Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease</title>
<link>https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-medicine-announces-the-new-england-journal-of-medicine-publication-of-pm359-clinical-data-for-the-treatment-of-chronic-granulomatous-disease</link>
<guid isPermaLink="true">https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-medicine-announces-the-new-england-journal-of-medicine-publication-of-pm359-clinical-data-for-the-treatment-of-chronic-granulomatous-disease</guid>
<pubDate>Sun, 07 Dec 2025 13:05:00 GMT</pubDate>
<description>CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotec...</description>
</item>
<item>
<title>Prime Medicine to Present at 8th Annual Evercore Healthcare Conference</title>
<link>https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-medicine-to-present-at-8th-annual-evercore-healthcare-conference</link>
<guid isPermaLink="true">https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-medicine-to-present-at-8th-annual-evercore-healthcare-conference</guid>
<pubDate>Tue, 25 Nov 2025 13:00:00 GMT</pubDate>
<description>CAMBRIDGE, Mass., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotec...</description>
</item>
<item>
<title>Prime Medicine to Present at Jefferies Global Healthcare Conference</title>
<link>https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-medicine-to-present-at-jefferies-global-healthcare-conference</link>
<guid isPermaLink="true">https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-medicine-to-present-at-jefferies-global-healthcare-conference</guid>
<pubDate>Tue, 11 Nov 2025 13:00:00 GMT</pubDate>
<description>CAMBRIDGE, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotec...</description>
</item>
<item>
<title>CORRECTION - Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates</title>
<link>https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/correction-prime-medicine-reports-third-quarter-2025-financial-results-and-provides-business-updates</link>
<guid isPermaLink="true">https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/correction-prime-medicine-reports-third-quarter-2025-financial-results-and-provides-business-updates</guid>
<pubDate>Fri, 07 Nov 2025 15:21:45 GMT</pubDate>
<description>-- New preclinical data for PM577 in Wilson&#x2019;s Disease (WD) to be presented at AASLD; on-tr...</description>
</item>
<item>
<title>Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates</title>
<link>https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-medicine-reports-third-quarter-2025-financial-results-and-provides-business-updates</link>
<guid isPermaLink="true">https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-medicine-reports-third-quarter-2025-financial-results-and-provides-business-updates</guid>
<pubDate>Fri, 07 Nov 2025 12:00:00 GMT</pubDate>
<description>-- New preclinical data for PM577 in Wilson&#x2019;s Disease (WD) to be presented at AASLD; on-tr...</description>
</item>
<item>
<title>Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer</title>
<link>https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-medicine-appoints-matthew-hawryluk-phd-mba-as-chief-business-officer</link>
<guid isPermaLink="true">https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-medicine-appoints-matthew-hawryluk-phd-mba-as-chief-business-officer</guid>
<pubDate>Mon, 03 Nov 2025 13:01:00 GMT</pubDate>
<description>CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotec...</description>
</item>
<item>
<title>Prime Medicine to Host Virtual KOL Event to Showcase Wilson's Disease Strategy</title>
<link>https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-medicine-to-host-virtual-kol-event-to-showcase-wilsons-disease-strategy</link>
<guid isPermaLink="true">https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-medicine-to-host-virtual-kol-event-to-showcase-wilsons-disease-strategy</guid>
<pubDate>Thu, 30 Oct 2025 20:01:00 GMT</pubDate>
<description>CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotec...</description>
</item>
<item>
<title>Prime Medicine to Participate in Upcoming Investor Conferences</title>
<link>https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-medicine-to-participate-in-upcoming-investor-conferences</link>
<guid isPermaLink="true">https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-medicine-to-participate-in-upcoming-investor-conferences</guid>
<pubDate>Tue, 07 Oct 2025 12:00:00 GMT</pubDate>
<description>CAMBRIDGE, Mass., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotec...</description>
</item>
<item>
<title>Prime Drink Group Provides Bi-Weekly MCTO Status Report</title>
<link>https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-drink-group-provides-bi-223000677</link>
<guid isPermaLink="true">https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-drink-group-provides-bi-223000677</guid>
<pubDate>Fri, 12 Sep 2025 22:30:00 GMT</pubDate>
<description>MONTREAL, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces that further to its news releases dated July 30, August 15, and August 29, 2025, the Company voluntarily applied for and the Company’s principal regulator, the British Columbia Securities Commission (the “BCSC”) granted a management cease trade order (the “MCTO”) dated July 30, 2025, under National Policy 12-203 Management Cease Trade Orders (“NP 12-203”) and provided the Company</description>
</item>
<item>
<title>Prime Drink Group Terminates Rights Offering and Announces Private Placement</title>
<link>https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-drink-group-terminates-rights-223000321</link>
<guid isPermaLink="true">https://6ix.com/company/prime-drink-group-corp-formerly-was-dwrdominion-water-reserves-corp-until-2022-11-22/news/prime-drink-group-terminates-rights-223000321</guid>
<pubDate>Thu, 04 Sep 2025 22:30:00 GMT</pubDate>
<description>MONTREAL, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces that it has terminated its previously disclosed rights offering and that it is proceeding with a non-brokered private placement offering of units of the Company (the “Units”) to raise maximum gross proceeds of $5,000,000 (the “Unit Offering”). Each Unit will be offered at a price of $5,000 per Unit and is comprised of 62,500 common shares in the capital of the Company (the “Commo</description>
</item>
</channel>
</rss>